MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
EMBC — Embecta Corp. Common Stock
NasdaqEmbecta Corp. Common Stock
$5.65
-0.14(-2.42%)
- O
- 5.79
- H
- 5.82
- L
- 5.49
- V
- 1.13M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About EMBC
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateMar 21, 2022
Employees1,850
Stock ExchangeNasdaq
Ticker SymbolEMBC
Websitehttps://www.embecta.com
Key Financial Statistics
| Market Cap | $320.13M |
| P/E Ratio | N/A |
| Dividend Yield | 0.71% (Quarterly) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.77 - $14.91 |
| 52-Week Avg Volume | 1.29M |
| VWAP | $5.64 |
| Transactions | 11,015 |
| Total Recorded Bars | 1,138 days |